Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (91-100 of 372) with videos related to

Pageof 38
Sort By:
Journal of the National Cancer Institute|May 3, 2018
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease StageLauren C Peres, Kara L Cushing-Haugen, Martin Köbel, et al.
Evidence Report/Technology Assessment|September 4, 2007
Genomic tests for ovarian cancer detection and managementEvan R Myers, Laura J Havrilesky, Shalini L Kulasingam, et al.
World Journal of Surgical Oncology|May 12, 2019
Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinomaAshley E Veade, Jonathan Foote, Jessie Ehrisman, et al.
Cancer|May 21, 2011
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancerLaura J Havrilesky, Robin Pokrzywinski, Dennis Revicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster, Robert M Wenham, Susan Halabi, et al.
Gynecologic Oncology Reports|July 26, 2016
Performance of sentinel lymph node biopsy in high-risk endometrial cancerJessie Ehrisman, Angeles Alvarez Secord, Andrew Berchuck, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: genome copy number abnormalities in ovarian cancerJoe W Gray, Seiji Suzuki, Wen-Lin Kuo, et al.
Gynecologic Oncology|July 1, 2008
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrenceLaura J Havrilesky, Clark M Whitehead, Jennifer M Rubatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarrayMichael A Bidus, John I Risinger, Gadisetti V R Chandramouli, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Regulation of Age-Related Lipid Metabolism in Ovarian CancerJihua Feng, Clay Douglas Rouse, Isabella Coogan, et al.
Pageof 38

Showing results (91-100 of 372) with videos related to

Sort By:
Pageof 38
Journal of the National Cancer Institute|May 3, 2018
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease StageLauren C Peres, Kara L Cushing-Haugen, Martin Köbel, et al.
Evidence Report/Technology Assessment|September 4, 2007
Genomic tests for ovarian cancer detection and managementEvan R Myers, Laura J Havrilesky, Shalini L Kulasingam, et al.
World Journal of Surgical Oncology|May 12, 2019
Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinomaAshley E Veade, Jonathan Foote, Jessie Ehrisman, et al.
Cancer|May 21, 2011
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancerLaura J Havrilesky, Robin Pokrzywinski, Dennis Revicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster, Robert M Wenham, Susan Halabi, et al.
Gynecologic Oncology Reports|July 26, 2016
Performance of sentinel lymph node biopsy in high-risk endometrial cancerJessie Ehrisman, Angeles Alvarez Secord, Andrew Berchuck, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: genome copy number abnormalities in ovarian cancerJoe W Gray, Seiji Suzuki, Wen-Lin Kuo, et al.
Gynecologic Oncology|July 1, 2008
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrenceLaura J Havrilesky, Clark M Whitehead, Jennifer M Rubatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarrayMichael A Bidus, John I Risinger, Gadisetti V R Chandramouli, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Regulation of Age-Related Lipid Metabolism in Ovarian CancerJihua Feng, Clay Douglas Rouse, Isabella Coogan, et al.
Pageof 38